Daily Care News for August 17, 2022
advertisement
- 30% of adults with type 1 diabetes have high fear of hypoglycemia
- HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
- Does Daily Insulin Dose Affect Cancer Risk in Patients With Type 1 Diabetes?
- COVID-19 Infection And Autoimmunity Not Linked To Developing Type 1 Diabetes In Children: JAMA
- SGLTi Therapy Decreases Long-Term CVD and End-Stage Kidney Disease Risk in Type 1 Diabetes
- Januvia’s Nitrosamine Contamination; COVID & Type 1 Diabetes; Vegans Who Lift
- SARS-CoV-2 Infection Not Associated with Autoimmunity Related to T1D Development
- Recognition, respect crucial for delivering culturally appropriate care in diabetes
- Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes (Full text HTML, PDF)
- Do-it-yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Healthcare Providers
- Continuous subcutaneous insulin infusion in type 1 diabetes mellitus patients: results from the Spanish national registry
- Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and Technology
- Fear of hypoglycemia and quality of life in young people with type 1 diabetes and their parents in the era of sensor glucose monitoring (Full text HTML, PDF)
- Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes
- American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update
- Association between a low carbohydrate diet, glycemic control, and quality of life in Australian adults living with type 1 diabetes: a pilot study
- Practical Screening for Islet Autoantibodies: The Time Has Come
- Safety and Efficacy of Eucaloric Very Low-Carb Diet (EVLCD) in Type 1 Diabetes: A One-Year Real-Life Retrospective Experience (Full text HTML, PDF)
- Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes (Full text HTML, PDF)
- Physical Activity and Nutrition Interventions for Type 1 Diabetes: A Meta-analysis
- Feasibility, Acceptability, and Preliminary Efficacy of an Intensive Clinic-Based Intervention for Children with Poorly Controlled Type 1 Diabetes
- A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes (Full text HTML, PDF)
- Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018 (Full text HTML, PDF)
- Mortality after discharge from hospital following an episode of diabetic ketoacidosis
- Randomised controlled trial of the Healthy Living Triple P-Positive Parenting Program for families of children with type 1 diabetes
- Utilizing the New Glucometrics: A Practical Guide to Ambulatory Glucose Profile Interpretation (Full text HTML, PDF)
- Improved CGM Glucometrics and More Visits in Pediatric Type 1 Diabetes using Telemedicine During 1 Year of COVID-19
- “Fear that one day I may not be able to afford insulin.” The emotional burden of diabetes costs during emerging adulthood
- DIgestive COmplications in DIabetes – the DICODI population study
- VIDEO: ‘Claim your space’ as diabetes — and technology — expert
- Time in range use lacking among primary care providers and patients
- Black, white parents differ in perspectives on pediatric diabetes device use
- Greater engagement with diabetes care linked to lower glucose levels for young people
- Continuous glucose monitor use varies by age, highest in middle adulthood
- Adults with type 1 diabetes have ‘moderate’ diabetes distress even with CGM use